Advancing Drug Discovery Through Innovative Technologies & Strategic Collaboration
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Target Discovery
Pivot Park Screening Centre: We Help You to Accelerate Drug Discovery
Are you looking for lead candidate compounds for your target or cellular phenotype, and do you want your drug discovery program to be more efficient, both in terms of time and cost?
Molecular Drug Design
Interview with Sridevi Nagarajan, Head Digital Regulatory Strategy at AstraZeneca
AstraZeneca’s Sridevi Nagarajan discusses the importance of artificial intelligence, strategic collaboration, and the role of the metaverse in unlocking the future of digital regulatory.
Organ Modelling
Experts Discuss Next Generation Organoids: Challenges and the Future
How do scientists secure the tissue they need? Should scientists be careful with the words they use for next generation technologies? And why is validation for organ modelling so important?
Organ Modelling
Changing How We Look at Tumours
Building 3D cell culture models for predictive in vivo and translational results
Organ Modelling
Cultrex™ Extracellular Matrix And Proteins
CultrexTM Basement Membrane Extract (BME)
Organ Modelling
Newcells Products and Services
We build custom, functional in vitro models, mimicking in vivo physiology, to improve clinical translation and accelerate drug discovery
Chemical Biology
Interview with Yusuke Tominari, Co founder and CEO of Fimecs
Yusuke will be giving a keynote presentation at Discovery Europe 2023 titled 'Targeted Protein Degradation And Addressing Undruggable Targets'.
Target Discovery
Tailor-made ADME-Tox
Admescope is a contract research organisation (CRO) providing the pharmaceutical industry with tailor-made ADME-Tox services to support the discovery and development of small molecules and biologics.